Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 4 × Oxycodone × Breast × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 2 Tumor-Agnostic 1 Thoracic 1 Other 1 Genitourinary 1 Breast 1

Conditions

Breast Neoplasms 1 Acute Pain 1

Interventions

Letrozole 18 Docetaxel 12 Anastrozole 12 exemestane 10 Tamoxifen 10 Cyclophosphamide 9 Zoledronic Acid 8 Trastuzumab 8 Paclitaxel 8 Capecitabine 8 Saline Solution 7 Bupivacaine 7 pegfilgrastim 6 Fulvestrant 6 Filgrastim 6 liposomal doxorubicin 5 Sodium Chloride 5 Ropivacaine 5 Dexmedetomidine 5 Bevacizumab 5 Tranexamic Acid 4 Sevoflurane 4 Epirubicin 4 trastuzumab deruxtecan 3 technetium-diethylenetriaminepentaacetic acid-mannosyl-dextran 3 ribociclib 3 pertuzumab 3 palbociclib 3 eribulin 3 abemaciclib 3

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04726878 2021-11-09

ESP in Breast Surgery Due to Cancer

Medical University of Lublin

Phase 4 Completed

Breast Neoplasms, Acute Pain

Data powered by HemOnc (CC BY 4.0) Colophon ⚡